We had several members of our family we lost to cancer, needless to say cancer was on my mind when I wrote this song, and in writing this new release it is a tribute to everyone we've lost to all forms of cancer in men and women and children we lost through the years and to their families and to those battling cancer today. God be with them all.
Thank you for listening to my new release and for sharing my new release, with those you know will be touched by this song.
We are all more than a memory to this life and in everything we do in this life, don't take this life for granted and never take the music business for granted.

https://youtu.be/bnqrjYUjGvk?feature=shared

"Who's ready for some new tunes? I just dropped my latest song, [You Are More Than A Memory]
Give it a listen, share with your friends, and let's get this song trending! #newmusic #musiclover"

https://youtu.be/7BlM4ToPwAc?feature=shared

01 New Release_ You're More Than A Memory Wm Curtis Music Owner of Publishing & Copyright

Did you know that according to research provided by the American Cancer Society, more than 2 million Americans will be diagnosed with cancer in 2025? Tune in for an inspiring discussion with Mohit Manrao, Senior Vice President of US Oncology at AstraZeneca, on the rising caner rates among younger adults. 
 
Moments with Marianne airs in the Southern California area on KMET 1490AM & 98.1 FM, an ABC Talk News Radio Affiliate!  https://www.kmet1490am.com

Mohit Manrao, Senior Vice President and Head of the US Oncology Business Unit at AstraZeneca, is responsible for leading commercial strategy and maximizing performance of their expansive oncology portfolio. Prior to assuming his current role in 2022, Mohit served as Vice President, Global Franchise Head Lung Cancer since 2020. Mohit joined AstraZeneca in 2012, holding various roles at the market, regional, and global-level across geographies, including Head of UK Oncology and Head of Daiichi Sankyo Alliance Europe. Mohit’s education includes Bachelor of Technology, Mechanical Engineering, Punjab Technical University and Masters of Business Administration, Indian School of Business. https://www.astrazeneca.com

For more show information visit:
www.MariannePestana.com

Rising Cancer Rates in Younger Adults with Mohit Manrao from AstraZeneca

In this episode, we examine how machine learning and artificial intelligence (AI) are becoming essential tools for improving image analysis of 3D samples. These technologies are reshaping research workflows by making analysis faster and more insightful.

We speak with Professor Jens Christian Schwamborn, Professor of Cellular and Developmental Biology at the University of Luxembourg, and Professor Christophe Deben, Professor of Tumour Biology and Organoids at the University of Antwerp. They share their perspectives on the current challenges in 3D sample analysis and how AI is helping to solve them - reducing processing time and revealing previously inaccessible information.

We'll look at the key reasons behind AI’s growing use in 3D image analysis, identify the limitations of existing imaging technologies, and explore how AI is evolving to handle increasingly complex data. We'll also discuss how the availability of large datasets is accelerating this shift and what breakthroughs AI could enable in the near future.

Machine Learning and AI in Enhancing Image Analysis of 3D Samples

This episode, 'Translating Promising Drug Candidates from Preclinical Screening to Clinical Trials,' will explore the challenges and successes of moving promising drug candidates from preclinical screening to clinical trials in oncology.

Join Dr. Steve Shnyder, Associate Professor at the Institute of Cancer Therapeutics, University of Bradford, as he explores:

- The unique challenges in oncology drug development.
- Preclinical model limitations and needed innovations.
- Translating preclinical insights into effective clinical trial design.
- The role of AI and machine learning in overcoming development hurdles.
- Real-world case studies of successful oncology drug approvals.



ranslating Promising Drug Candidates from Preclinical Screening to Clinical Trials

How is artificial intelligence being used in cancer care, and what do patients think about it?

In this 'Ask Me Anything' episode, Ellie Wolmark, Programme Manager for Integrated Cancer Medicine (ICM) at the CRUK Cambridge Centre, speaks with patient representatives Lorraine, Frankie, and Ann from across our Patient and Public Involvement groups, alongside ICM researchers Professor James Brenton, Dr Ines Machado, and Dr Gabriel Funingana from the University of Cambridge.

Together, they explore how artificial intelligence (AI) is being applied in cancer research, how it could support personalised treatment, and what the future might hold. The patients share thoughtful questions and concerns about the role of AI in healthcare, while the researchers explain how it's currently being used and what challenges remain.

This lively and insightful discussion highlights just how valuable patient involvement is in shaping research that truly meets the needs of those it aims to help.

Ask me anything about cancer

Ask me anything about... the use of artificial intelligence in healthcare

Why does eating more not fix the severe weight loss seen in some cancer patients, and what can be done about it?

In this 'Ask Me Anything' episode, Dr Hui-Ling Ou, Programme Manager for the Pancreatic Cancer and Cancer Immunology Programmes at the CRUK Cambridge Centre, speaks with researchers from the Cancer Cachexia Action Network (CANCAN): Dr Claire Connell (University of Cambridge and Cambridge University Hospitals NHS Foundation Trust), Dr David Lewis (CRUK Scotland Institute), and Dr Tobias Janowitz (Cold Spring Harbor Laboratory).

Together, they unpack what cancer-associated cachexia is, why it's so devastating for patients, and how scientists are working to understand and reverse this syndrome. The guests share how their research, spanning metabolism, imaging, immunology, and clinical studies, is bringing fresh insights and hope to a problem that affects quality of life for so many.

This thought-provoking discussion shines a light on the collaborative efforts driving progress against one of cancer's most challenging complications.

Ask me anything about... the science of cancer-associated cachexia

What do you most want to know about pancreatic cancer and cancer-associated cachexia?

In this special episode, we bring you a recording of a live 'Ask Me Anything (AMA)' event hosted by the CRUK Cambridge Centre Pancreatic Cancer Programme for World Pancreatic Cancer Day 2024.

A multidisciplinary and international panel of experts, including clinicians, researchers, nurses, dietitians and physiotherapists, answer thoughtful questions from the public about pancreatic cancer, cachexia and the latest research and care approaches. Topics range from understanding the biology of these diseases to managing symptoms and improving quality of life.

The discussion sheds light on the progress being made and the ongoing challenges in improving outcomes for people affected by these conditions.

Ask me anything about... cachexia research and management

Breakthroughs in cancer research are playing a pivotal role in advancing treatments and therapies to fight the disease. Discover Advancements in Cancer Research, Treatments, and Therapies, inside this edition of CTSI Discovery Radio!

Episode #136 - Advancements in Cancer Research, Treatments & Therapies

How can artificial intelligence (AI) support both cancer research and healthcare more generally? Anoushka Harit (University of Cambridge) and Dr Zhongtian Sun (University of Kent) join today's episode to discuss this topic.

Anoushka talks about her research in hereditary diffuse gastric cancer (HDGC) and the development of an AI system to enable early detection of signet ring cell carcinoma (SRCC) during endoscopy. This new AI system could help to treat SRCC better or to prevent or delay drastic life-changing treatment, preserving patients' quality of life.

Zhongtian shares insights on how AI can support health applications more generally and how he tries to make it as explainable as possible. He even talks about his wish to make the AI mimic as much as possible the way a human brain works!

Integrated Cancer Medicine: Research in Focus

Using AI to detect stomach cancer during endoscopy

Have you ever wondered how artificial intelligence (AI) is used in research in a healthcare setting? Rebecca Wray and Bill McGough, two PhD students at the University of Cambridge, both use AI in different ways in their research into the screening and treatment of kidney cancer.

Rebecca is an MRes PhD student investigating the response and resistance to therapy in patients with kidney cancer. She uses AI to find tumour features at multiple scales. For his PhD, Bill is developing AI models that will sift through the mounds of imaging data produced during the Yorkshire Kidney Screening Trial (funded by Yorkshire Cancer Research), flagging images that show masses in the kidneys.

This interesting conversation gives insight into how researchers are using patient data safely in order for AI models to integrate all the information about a patient to help review their treatment and personalise it. The discussion also highlights how using AI in the screening setting is speeding up processes to help save clinicians' time and allowing the potential earlier detection of kidney cancer in a cost-effective manner.

Using AI in the screening and treatment of kidney cancer

Just your ordinary songwriter and composer of music among 80 million of other global songwriters.
Boxed up in one category.
The art of music is hidden inside all of us that believe.
You’ve got to have reason and purpose to succeed.
It’s not a matter of who believes in you, the question is do you believe in you.
Compete against no one but yourself 


STIM. Songwriter.
Thank you for your donations.

CTSI Discovery Radio is a unique facet of the Clinical & Translation Science Institute (CTSI) of Southeast Wisconsin. Each 30-minute monthly show informs and educates listeners about translational research relative to current health topics, clinical studies and advancements in biomedical research leading to better outcomes. CTSI Discovery Radio is hosted and produced by award-winning veteran radio personality Bryan Belmer.

Visit the CTSI website at https://ctsi.mcw.edu

In a single moment your life can change!  “Moments with Marianne” is a transformative hour that covers an endless array of topics with the ‘best of the best.’ Her guest are leaders in their fields, ranging from inspirational authors, top industry leaders, business and spiritual entrepreneurs.  Each guest is gifted, and a true visionary!  A recognized leader in her own work, and while teaching others to develop, refocus, and grow; Marianne will bring the best guest, and sometimes a special surprise.  Don’t miss this – you never know just which ‘moment’ will change your life forever.

The Cancer Research UK Cambridge Centre unites over 1,000 world-leading biologists, chemists, physicists, engineers, mathematicians, computer scientists, clinicians, nurses and allied healthcare professionals from across Cambridge, UK to tackle cancer from every angle.

Our mission is to end death and disease caused by cancer through research, treatment and education. We are detecting cancer at its earliest stage and are developing personalised treatments for every patient through facilitating new collaborations and driving the translation of new scientific discoveries into clinical applications to improve patient care. By working together across a range of different disciplines, our members are breaking down the barriers between the laboratory and the clinic, enabling patients to benefit from the latest innovations in cancer science.

New tracks tagged #Cancer Research